Ataraxis Breast RISK
About this test
Ataraxis® Breast RISK is a comprehensive breast cancer recurrence risk test.
Ataraxis Breast RISK is the first clinically validated prognostic test based entirely on artificial intelligence (AI), intended for patients with invasive breast cancer at stages I–III. It uses multidimensional AI to analyse H&E-stained slides and clinical data to predict treatment outcomes and support personalised therapeutic decisions across all breast cancer subtypes.
The test material is an H&E slide (preparation) from a biopsy or surgery. A copy of the histopathology report must be delivered to the laboratory together with the material.
When ordering the test, use the code: ATARAXIS
How the test works
-
1
Order online
No referral needed. You order online.
-
2
Send the material
You send the material (e.g. a histopathology slide) to the laboratory.
-
3
Result
Available online.
Frequently asked questions
Do I need a referral?
No. You can order this genetic test online without a referral.
How much does the test cost?
The price of the test is 3300 PLN.
Ready to order Ataraxis Breast RISK
Order online — no referral needed.